Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Grima

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Journal of Cardiovascular Pharmacology|January 1, 1989
Assay of tissue angiotensin converting enzymeC Welsch, M Grima, E M Giesen, et al.
Diabetes & Metabolism|May 15, 2003
Mild acute renal failure potentiates metformin accumulation in the diabetic rat kidney without further impairment of renal functionM Barthelmebs, N Wiernsperger, J P Krieger, et al.
Journal of Cardiovascular Pharmacology|December 1, 1995
Endothelium-dependent relaxation in the isolated rat kidney: impairment by cyclosporine AD Stephan, A Billing, J P Krieger, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 24, 2013
The integration of high-throughput testing of blood donors for cardiovascular disease risk assessment and preventionDebra A Kessler, Kathleen M Grima, Jay E Valinsky, et al.
AJNR. American Journal of Neuroradiology|September 29, 2018
Expanding the Distinctive Neuroimaging Phenotype of <i>ACTA2</i> MutationsF D'Arco, C A Alves, C Raybaud, et al.
Journal of the National Cancer Institute|September 5, 1990
Phase I study of high-dose continuous-infusion recombinant interleukin-2 and autologous lymphokine-activated killer cells in patients with metastatic or unresectable malignant melanoma and renal cell carcinomaE R Gaynor, G R Weiss, K A Margolin, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2012
Discovery of a novel class of zwitterionic, potent, selective and orally active S1P₁ direct agonistsNuria Aguilar, Marta Mir, Pedro M Grima, et al.
Vox Sanguinis|March 23, 2021
International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: ResponsesMindy Goldman, Mary Townsend, Karin Magnussen, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Journal of Cardiovascular Pharmacology|January 1, 1989
Assay of tissue angiotensin converting enzymeC Welsch, M Grima, E M Giesen, et al.
Diabetes & Metabolism|May 15, 2003
Mild acute renal failure potentiates metformin accumulation in the diabetic rat kidney without further impairment of renal functionM Barthelmebs, N Wiernsperger, J P Krieger, et al.
Journal of Cardiovascular Pharmacology|December 1, 1995
Endothelium-dependent relaxation in the isolated rat kidney: impairment by cyclosporine AD Stephan, A Billing, J P Krieger, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 24, 2013
The integration of high-throughput testing of blood donors for cardiovascular disease risk assessment and preventionDebra A Kessler, Kathleen M Grima, Jay E Valinsky, et al.
AJNR. American Journal of Neuroradiology|September 29, 2018
Expanding the Distinctive Neuroimaging Phenotype of <i>ACTA2</i> MutationsF D'Arco, C A Alves, C Raybaud, et al.
Journal of the National Cancer Institute|September 5, 1990
Phase I study of high-dose continuous-infusion recombinant interleukin-2 and autologous lymphokine-activated killer cells in patients with metastatic or unresectable malignant melanoma and renal cell carcinomaE R Gaynor, G R Weiss, K A Margolin, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2012
Discovery of a novel class of zwitterionic, potent, selective and orally active S1P₁ direct agonistsNuria Aguilar, Marta Mir, Pedro M Grima, et al.
Vox Sanguinis|March 23, 2021
International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: ResponsesMindy Goldman, Mary Townsend, Karin Magnussen, et al.
Pageof 9